C. Mannina

Natural approaches in metabolic syndrome management

G. Lippi, M. Banach, M. Rizzo, 2017, Archives of medical science : AMS.

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms.

M. Rizzo, A. Rizvi, F. Cosentino, 2018, Biochimica et biophysica acta. Molecular basis of disease.

Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care

M. Boemi, E. Bonora, A. Avogaro, 2021, Journal of Endocrinological Investigation.

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

M. Boemi, E. Bonora, A. Avogaro, 2021, Cardiovascular Diabetology.

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity.

M. Boemi, E. Bonora, A. Avogaro, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.